Investors

To download our documents

To receive OSE Immunotherapeutics’ latest news

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price

ISIN

FR0012127173

Ticker

OSE

Type of listing

Continuous

Number of outstanding shares

17,896,789 shares as of 31 December 2020

Eligibility

Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

30 March 2022

Annual financial results 2021

23 June 2022

General shareholders' meeting

22 September 2022

Half-year results 2022

Analysts

Read more
Degroof Petercam
David Seynnaeve
Invest Securities
Jamila El Bougrini
Edison
Jonas Peciulis

Analyst reports

Read more
19/10/2021 Bryan, Garnier & Co
15/10/2021 Maxim Group
02/09/2021 Maxim Group

Regulated information

Read more

General shareholders' meetings

Read more
24/06/2021

General Shareholders' Meeting 2021

All the documents below are in French

Financial information and publications

Read more
2021 First-half 2021 financial report
2020 First-half 2020 financial report
2020 2020 Universal registration document